WallStreetZenWallStreetZen

NYSEMKT: NRXS
Neuraxis Inc Stock

$2.56-0.02 (-0.78%)
Updated Jun 24, 2024
NRXS Price
$2.56
Fair Value Price
N/A
Market Cap
$17.02M
52 Week Low
$1.80
52 Week High
$6.93
P/E
-0.69x
P/B
-5.34x
P/S
8.88x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.30M
Earnings
-$14.57M
Gross Margin
87.7%
Operating Margin
-618.16%
Profit Margin
-633.2%
Debt to Equity
-1.3
Operating Cash Flow
-$7M
Beta
1.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NRXS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NRXS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NRXS is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
NRXS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more NRXS due diligence checks available for Premium users.

Be the first to know about important NRXS news, forecast changes, insider trades & much more!

Valuation

NRXS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.69x
Industry
-6.96x
Market
30.03x

NRXS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-5.34x
Industry
6.29x

NRXS's financial health

Profit margin

Revenue
$646.6k
Net Income
-$2.1M
Profit Margin
-328%
NRXS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NRXS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$945.7k
Liabilities
$4.1M
Debt to equity
-1.3
NRXS's short-term liabilities ($3.82M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NRXS's short-term assets ($407.83k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NRXS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NRXS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.3M
Investing
-$14.7k
Financing
$1.4M
NRXS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NRXS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NRXS$17.02M-0.78%-0.69x-5.34x
GLYC$17.21M+3.89%-0.46x0.60x
VINC$17.48M-1.33%-0.33x-28.11x
PMCB$17.61M+6.67%-1.73x0.56x
VBIV$17.75M+3.51%-0.11x-3.25x

Neuraxis Stock FAQ

What is Neuraxis's quote symbol?

(NYSEMKT: NRXS) Neuraxis trades on the NYSEMKT under the ticker symbol NRXS. Neuraxis stock quotes can also be displayed as NYSEMKT: NRXS.

If you're new to stock investing, here's how to buy Neuraxis stock.

What is the 52 week high and low for Neuraxis (NYSEMKT: NRXS)?

(NYSEMKT: NRXS) Neuraxis's 52-week high was $6.93, and its 52-week low was $1.80. It is currently -63.06% from its 52-week high and 42.22% from its 52-week low.

How much is Neuraxis's stock price per share?

(NYSEMKT: NRXS) Neuraxis stock price per share is $2.56 today (as of Jun 24, 2024).

What is Neuraxis's Market Cap?

(NYSEMKT: NRXS) Neuraxis's market cap is $17.02M, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neuraxis's market cap is calculated by multiplying NRXS's current stock price of $2.56 by NRXS's total outstanding shares of 6,647,960.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.